Chemed Corp: Form 10-Q for the period ended Mar 31, 2014
Filed with the SEC on May 2, 2014 and accepted by EDGAR at May 2, 2014, 08:50 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2014-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2014-01-01 to 2014-03-31 | $358.3m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2014-01-01 to 2014-03-31 | $257.8m | us-gaap:CostOfRevenue |
| Selling, general and administrative | 3 months2014-01-01 to 2014-03-31 | $55.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2014-01-01 to 2014-03-31 | $36.7m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2014-01-01 to 2014-03-31 | $3.8m | us-gaap:InterestExpense |
| Income tax | 3 months2014-01-01 to 2014-03-31 | $13.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2014-01-01 to 2014-03-31 | $20.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2014-01-01 to 2014-03-31 | $1.12 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2014-01-01 to 2014-03-31 | $1.17 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2014-01-01 to 2014-03-31 | 18,305,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2014-01-01 to 2014-03-31 | −$11.8m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 3 months2014-01-01 to 2014-03-31 | $8.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2014-01-01 to 2014-03-31 | $3.3m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months2014-01-01 to 2014-03-31 | $33.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2014-03-31 | $39.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2014-03-31 | $198.4m | us-gaap:AssetsCurrent |
| Total assets | At period end2014-03-31 | $868.6m | us-gaap:Assets |
| Current liabilities | At period end2014-03-31 | $337.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2014-03-31 | $422.7m | us-gaap:Liabilities |
| Long-term debt | At period end2014-03-31 | $185.8m | us-gaap:LongTermDebt |
| Current portion of debt | At period end2014-03-31 | $185.8m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2014-03-31 | $445.9m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2014-03-31 | 17,539,101 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001157523-14-001833. Last ingested by Listed: Nov 14, 2026, 12:29 ET. Listed shows no prices and gives no investment advice.